Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Qwaqwa Campus honours academic excellence
2014-05-21


Photo: Sonia Small (Kaleidoscope Studios)

  • Photo Gallery

      Our Qwaqwa Campus was this past weekend a hive of activity when graduates, their parents and well-wishers descended on the campus to honour outstanding academic excellence during the Winter Graduation ceremonies.

      On Friday graduates from the Faculty of Humanities, as well as the Faculty of Economic and Management Sciences, were addressed by Tommy Makhatho, Managing Director of the Qwaqwa-based Bibi Cash and Carry.

      Makhatho urged graduates to continue working hard way beyond their graduation day and to dream big.

      “Dream big and don’t let your poor background hold you back,” Makhatho said.

      “Don’t let people say you can’t or that you will fail. Take up one idea. Make that one idea your life, think of it, dream of it, live on that idea, let your brain, muscle, nerves and every part of your body be full of that idea and leave every other idea alone. This is the way to success. If you don’t build your dream, someone else will hire you to help them build theirs,” said Makhatho, the winner of the 2013 Sanlam/Business Partners Entrepreneur of the Year and Job Creator of the Year awards.

      On Saturday, graduates were treated to yet another moving message by eNCA’s news anchor, Mabale Moloi, herself a graduate in Biological sciences.

      “If there is one ability that we should all practice on a daily basis, it is work ethics. This is a value based on hard work and diligence,” Moloi said.

      Moloi further shared her views on what makes excellent work ethics.

      “There are five very important factors of work ethics that we all need to be aware of. One of them is reliability. This means how committed you are to completing a task that is given to you within a particular period of time,” said Moloi.

      “The second one is dedication. This means how prepared you are to go the extra mile in completing a job or your studies. Thirdly, one’s level of productivity is very important in having an excellent work ethic. This refers to giving the best of yourself, even to the extent of surpassing what is expected of you.”

      “Fourthly, there is co-operation. We all must understand the value of team work and how it leads to success. And this, when paired with character, self-discipline and strong personality, will distinguish you from anyone else,” Moloi added.

      Among the more than 800 degrees, diplomas and certificates conferred, were three PhDs in Physics, Polymer Science and Zoology, respectively. Four Masters of Science degrees were conferred cum laude.

    • We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

      Accept